Newborn Screening: Early Detection for Infants
Newborn screening is an early detection test performed shortly after birth to identify rare but treatable metabolic and hormonal disorders before symptoms appear.
Things worth knowing about "Newborn screening"
Newborn screening is an early detection test performed shortly after birth to identify rare but treatable metabolic and hormonal disorders before symptoms appear.
What is newborn screening?
Newborn screening (also called neonatal screening or newborn blood spot screening) is a standardized preventive health program carried out routinely shortly after birth. Its primary goal is to detect certain congenital disorders – particularly rare metabolic diseases, hormonal dysfunctions, and genetically caused conditions – early enough to begin treatment before the first symptoms arise. Early intervention can prevent severe health complications, developmental disabilities, or even death.
When and how is the screening performed?
Newborn screening is typically performed between 36 and 72 hours after birth. A small blood sample is collected from the infant, usually via a heel prick (also known as a heel stick). The blood drops are applied to specially designed filter paper cards (dried blood spot cards) and sent to an accredited screening laboratory.
In the laboratory, the blood samples are analyzed using advanced techniques – most notably tandem mass spectrometry (MS/MS) – which allows many different disorders to be detected simultaneously in a single analytical run.
Which conditions are screened for?
The specific disorders included in newborn screening panels vary by country and are regularly updated based on new evidence and treatment availability. Common conditions screened for include:
- Phenylketonuria (PKU): a metabolic disorder in which the amino acid phenylalanine cannot be properly broken down
- Congenital hypothyroidism: an underactive thyroid gland that can lead to developmental delays
- Congenital adrenal hyperplasia (CAH): a disorder affecting the adrenal glands
- Biotinidase deficiency: an enzyme deficiency that can cause neurological damage
- Galactosemia: a metabolic disorder affecting the processing of galactose (milk sugar)
- Cystic fibrosis: a serious disease affecting the exocrine glands
- Sickle cell disease: a genetic disorder of the red blood cells
- Various amino acid disorders, fatty acid oxidation disorders, and organic acidemias
In Germany, more than 20 conditions are currently included in the mandatory newborn screening panel, as defined by the Federal Joint Committee (G-BA).
What happens if the result is abnormal?
An abnormal screening result does not necessarily mean the child has the disease. An abnormal result triggers follow-up testing and specialist evaluation to confirm or rule out the suspected condition.
If a condition is confirmed, treatment can begin immediately – often before the child shows any clinical symptoms. The earlier treatment is started, the better the outlook for normal, healthy development.
Is newborn screening voluntary?
In Germany, newborn screening is voluntary but strongly recommended. Parents must give their informed consent before the test is carried out. The costs are fully covered by statutory health insurance. Medical associations and professional bodies strongly encourage participation, as timely therapy can prevent serious long-term harm.
Importance for child health
Newborn screening is considered one of the most effective preventive health measures in pediatric medicine. Thanks to early detection and treatment, children who would otherwise develop severe disabilities can lead largely healthy and normal lives. In Germany, approximately 750,000 newborns are screened each year.
References
- Federal Joint Committee (G-BA): Children's Guidelines – Newborn Screening. URL: https://www.g-ba.de (as of 2024)
- German Society for Newborn Screening (DGNS): Information on Newborn Screening. URL: https://www.screening-dgns.de (as of 2024)
- Hoffmann GF, Lindner M, Loeber JG: "50 years of newborn screening". Journal of Inherited Metabolic Disease, 2014; 37(2): 155–159. DOI: 10.1007/s10545-014-9697-4
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Newborn screening